These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3179638)

  • 1. Comparison of two dosage schedules of oral gold salts in the maintenance treatment of rheumatoid arthritis.
    Mathieu A; Pala R; Nurchis P; Garau P
    Br J Rheumatol; 1988 Oct; 27(5):416-7. PubMed ID: 3179638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Orally administered gold salts: auranofin].
    Passiu G
    Ann Ital Med Int; 1986 Dec; 1(4):329-32. PubMed ID: 3079375
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gold salts in the therapy of rheumatoid arthritis. Experience with an oral preparation].
    Magarò M; Zoli A; Altomonte L; Mirone L; Corvino G; Carelli G
    Recenti Prog Med; 1986 Jun; 77(6):319-20. PubMed ID: 3764073
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.
    Prete PE; Zane J; Krailo M; Bulanowski M
    Clin Rheumatol; 1994 Mar; 13(1):60-9. PubMed ID: 8187446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
    Atakhodzhaeva ZA; Sigidin IaA
    Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the clinico-therapeutic response to oral gold salts in patients with rheumatoid arthritis].
    Giordano N; Biasi G; Morozzi G; Taddeo A; Frati E; Marcolongo R; Paternò E
    Clin Ter; 1989 Mar; 128(5):343-6. PubMed ID: 2524321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Against parenteral gold therapy in rheumatoid arthritis].
    Kellner H
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of oral and parenteral gold therapy--review of the literature].
    Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():44-8. PubMed ID: 6442057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with oral gold salts in the treatment of rheumatoid arthritis in patients followed up for one year.
    Lignère GC; Giavarini S; Longatti S
    J Int Med Res; 1984; 12(3):193-7. PubMed ID: 6428946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of gold salts in Still's disease].
    Moccia F; Morra L
    Clin Ter; 1988 Dec; 127(6):431-4. PubMed ID: 2977316
    [No Abstract]   [Full Text] [Related]  

  • 13. Auranofin therapy in rheumatoid arthritis.
    Bernhard GC
    J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic therapy of rheumatoid arthritis with auranofin].
    Goebel KM
    Dtsch Med Wochenschr; 1985 Jan; 110(2):64-5. PubMed ID: 3917898
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and management of diarrhea during longterm auranofin therapy.
    Wallin BA; McCafferty JP; Fox MJ; Cooper DR; Goldschmidt MS
    J Rheumatol; 1988 Dec; 15(12):1755-8. PubMed ID: 3265956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on combined of auranofin, salazosulfapyridine and methotrexate in rheumatoid arthritis].
    Fujii T; Suwa A; Yosida T; Mimori T; Akizuki M
    Ryumachi; 1994 Jun; 34(3):571-82. PubMed ID: 7914383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
    Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.